Founded in 2009, SOM Biotech is a global leader in drug repurposing for rare diseases. With a strong pipeline focused on CNS disorders, including Huntington's disease and Adrenoleukodystrophy, SOM is headquartered in Barcelona and Cambridge, MA.
National Ranking2373rd
in Spain Regional Ranking27687th
in Western Europe Global Ranking111405th
worldwide Rankings by